| Not Yet Recruiting | Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica NCT07448363 | Caja Costarricense de Seguro Social | — |
| Not Yet Recruiting | The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease NCT07487831 | University of California, San Francisco | Phase 4 |
| Recruiting | Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD NCT07441395 | Corvus Pharmaceuticals, Inc. | Phase 2 |
| Not Yet Recruiting | Moisturization and Skin Hydration Study NCT07270965 | University of British Columbia | N/A |
| Not Yet Recruiting | Validation Of A Parent Administered Symptom Score For Unsettled Infants (Every Baby is UnIQue) NCT07121062 | University Hospital Southampton NHS Foundation Trust | — |
| Recruiting | A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic De NCT07037901 | Inmagene LLC | Phase 2 |
| Completed | Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis NCT06998056 | Arcutis Biotherapeutics, Inc. | Phase 2 |
| Active Not Recruiting | The Effects of an Oral Prebiotic and an Oral Synbiotic Supplement in Combination With a Topical Lotion and Soa NCT07041892 | Codex Labs Corporation | N/A |
| Recruiting | Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD. NCT06855745 | Alphyn Biologics | Phase 2 |
| Recruiting | Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis NCT06636240 | Taipei Medical University Shuang Ho Hospital | N/A |
| Recruiting | Herbal Ointment in Treating Atopic Dermatitis Topically NCT06850311 | En Chu Kong Hospital | Phase 2 / Phase 3 |
| Terminated | Topical ENS-002 for Atopic Dermatitis in Adults NCT06469385 | Concerto Biosciences | Phase 1 |
| Recruiting | Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individual NCT06454942 | National University of Singapore | N/A |
| Completed | The Effects of a Botanical Moisturizer, an Oral Supplement, and an Unscented Soap on Eczema and Itch NCT06819709 | Codex Labs Corporation | N/A |
| Completed | The Effects of a Botanical Moisturizer and an Unscented Soap on Eczema and Itch NCT06804070 | Codex Labs Corporation | N/A |
| Active Not Recruiting | Phase 2 Trial of HY209gel in Atopic Dermatitis Patients NCT06024499 | Shaperon | Phase 2 |
| Completed | The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia. NCT07046039 | King Abdulaziz University | — |
| Recruiting | DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema NCT06004986 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 4 |
| Terminated | This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe NCT05935085 | AnaptysBio, Inc. | Phase 2 |
| Unknown | The Efficacy of NTU 101 Lactic Acid Bacteria Powder in the Adjuvant Improvement of Atopic Dermatitis Clinical NCT05719649 | SunWay Biotech Co., LTD. | N/A |
| Active Not Recruiting | The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema) NCT05704205 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Completed | Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema NCT05918237 | ClinOhio Research Services, LLC | N/A |
| Unknown | Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis NCT05578482 | Jacob Pontoppidan Thyssen | Phase 4 |
| Completed | Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis NCT05579899 | Evommune, Inc. | Phase 2 |
| Terminated | A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects Wit NCT05382819 | Fresh Tracks Therapeutics, Inc. | Phase 1 |
| Completed | Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% NCT05461456 | OrchestratePharma GmbH | Phase 1 |
| Completed | Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children NCT06361992 | Catalysis SL | Phase 3 |
| Unknown | Metal Panel Allergen Patch Test Study NCT04500834 | Allerderm | Phase 3 |
| Unknown | Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic De NCT05136261 | KK Women's and Children's Hospital | Phase 3 |
| Recruiting | China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project NCT05316805 | Peking University First Hospital | — |
| Active Not Recruiting | Seal, Stopping Eczema and Allergy Study NCT03742414 | Kari Nadeau, MD, PhD | Phase 2 |
| Completed | Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED) NCT04845620 | Arcutis Biotherapeutics, Inc. | Phase 3 |
| Completed | Characterizing Skin Microbiome Change in Atopic Dermatitis NCT04800185 | University of California, Irvine | EARLY_Phase 1 |
| Completed | Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis NCT04804605 | Arcutis Biotherapeutics, Inc. | Phase 3 |
| Completed | Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II) NCT04773600 | Arcutis Biotherapeutics, Inc. | Phase 3 |
| Completed | Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis NCT04773587 | Arcutis Biotherapeutics, Inc. | Phase 3 |
| Unknown | Hand Sanitizer Effects on the Skin Barrier NCT04525521 | National Jewish Health | — |
| Completed | Tofacitinib for Immune Skin Conditions in Down Syndrome NCT04246372 | University of Colorado, Denver | Phase 2 |
| Completed | Skin Pathology Assessment With Optical Technologies NCT04295824 | Sheffield Teaching Hospitals NHS Foundation Trust | — |
| Unknown | Skin Barrier Assessment in Pregnancy and at Birth NCT04445298 | National Jewish Health | — |
| Completed | Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Modera NCT04156191 | Arcutis Biotherapeutics, Inc. | Phase 1 |
| Terminated | Effects of a Berry Oil Cream on Atopic Eczema and Skin NCT04085549 | Petra Larmo | N/A |
| Completed | Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis NCT03981926 | University of Southern California | N/A |
| Completed | Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier Function NCT04097327 | Bitop AG | — |
| Unknown | TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE) NCT03795506 | Imperial College London | N/A |
| Unknown | Study in Subjects With Moderate Atopic Dermatitis NCT03859986 | Ralexar Therapeutics, Inc. | Phase 2 |
| Completed | Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK) NCT03823794 | Momentum Data | — |
| Completed | The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients NCT03667014 | University of California, San Francisco | Phase 4 |
| Completed | Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis NCT03293030 | University of California, San Francisco | Phase 4 |
| Active Not Recruiting | Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over Time NCT04017520 | Milton S. Hershey Medical Center | — |
| Completed | Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis NCT03235024 | AOBiome LLC | Phase 2 |
| Completed | 8-Week Atopic Dermatitis (AD) Treatment Study NCT03386032 | Procter and Gamble | Phase 3 |
| Completed | Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis NCT03540043 | PurGenesis Technologies Inc. | Phase 2 |
| Completed | Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Applica NCT03090178 | Ad scientiam | N/A |
| Completed | Development of a Method to Measure mRNA Levels in Skin Samples NCT04537468 | Innovaderm Research Inc. | N/A |
| Completed | To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic S NCT02857062 | Reckitt Benckiser Healthcare (UK) Limited | N/A |
| Completed | Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis. NCT03268174 | AOBiome LLC | N/A |
| Completed | Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients NCT03158012 | University of California, San Diego | Phase 1 |
| Completed | Insulin Sensitivity in Patients With Atopic Dermatitis NCT03003793 | University Hospital, Gentofte, Copenhagen | — |
| Unknown | Atopic Dermatitis Adherence Study NCT02169986 | University of British Columbia | N/A |
| Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurolo NCT01931644 | Sanguine Biosciences | — |
| Unknown | Haut-Tief Patient Education on Psoriasis and Eczema NCT02205593 | University of Zurich | N/A |